Literature DB >> 19252403

Quality of life in patients with laryngopharyngeal reflux.

Ting Kin Cheung1, Paul K Y Lam, William Ignace Wei, Wai Man Wong, Manwa L Ng, Qing Gu, Ivan F Hung, Benjamin C Y Wong.   

Abstract

BACKGROUND: Laryngopharyngeal reflux (LPR) disease is an extraesophageal manifestation of gastroesophageal reflux disease (GERD). The impact of GERD-related LPR on the psychological well-being and quality of life (QOL) in Chinese is not known. AIM: To assess the QOL in patients with LPR disease.
METHODS: 76 LPR and 73 healthy subjects were recruited. Psychological well-being was assessed by the Hospital Anxiety and Depression Score and QOL was assessed by SF-36.
RESULTS: 51/76 (67.1%) patients had GERD-related LPR. More LPR subjects had taken sick leave (36.2 vs. 5.6%, p = 0.001) and reported adverse social life impact (60.5 vs. 38.9%, p = 0.013). LPR patients showed significantly worse results on the Voice Handicap Index (47.8 vs. 7.6, p = 0.001), were more anxious and had worse QOL in social functioning, pain and general health perception domains of SF-36. GERD-related LPR subjects had a higher depression score (4.8 vs. 3.8, p = 0.014) and a lower mental summary score (41.8 vs. 48.4, p = 0.01) in SF-36 compared with those without GERD.
CONCLUSIONS: LPR had a negative impact on psychological status, social functioning and QOL. GERD symptoms appeared to be the main contributor to decrease QOL. GERD-related LPR patients had a significant impact on the mental component of their QOL.

Entities:  

Mesh:

Year:  2008        PMID: 19252403     DOI: 10.1159/000205267

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  6 in total

1.  Prevention of esophagopharyngeal reflux by augmenting the upper esophageal sphincter pressure barrier.

Authors:  Reza Shaker; Arash Babaei; Sohrab R Naini
Journal:  Laryngoscope       Date:  2014-06-27       Impact factor: 3.325

2.  [Importance of functional endoscopy for diagnostics of extraesophageal reflux : relationship of Belafsky's reflux symptom index and functional endoscopic data].

Authors:  F Michel; R Dannesberger; R Fritsche; T Stroh; P Ahrens
Journal:  HNO       Date:  2014-11       Impact factor: 1.284

3.  The prevalence of laryngopharyngeal reflux in the English population.

Authors:  Tawakir Kamani; Susannah Penney; Indu Mitra; Vijay Pothula
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-11       Impact factor: 2.503

4.  Laryngopharyngeal reflux disease in the Greek general population, prevalence and risk factors.

Authors:  Nikolaos Spantideas; Eirini Drosou; Anastasia Bougea; Dimitrios Assimakopoulos
Journal:  BMC Ear Nose Throat Disord       Date:  2015-12-21

5.  Laryngopharyngeal reflux disease, prevalence and clinical characteristics in ENT department of a tertiary hospital Tanzania.

Authors:  Willybroad A Massawe; Aslam Nkya; Zefania Saitabau Abraham; Kassim M Babu; Ndeserua Moshi; Aveline A Kahinga; Daudi Ntunaguzi; Enica R Massawe
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-08-26

6.  TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.

Authors:  Gillian Watson; James O'Hara; Paul Carding; Jan Lecouturier; Deborah Stocken; Tony Fouweather; Janet Wilson
Journal:  Trials       Date:  2016-04-01       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.